Importance of diagnosis time on pregnancy outcomes in pregnant women with pre-gestational diabetes mellitus

Abstract

Importance of diagnosis time on pregnancy outcomes in pregnant women with pre-gestational diabetes mellitus Hongying Zhang1, Qingling Wei2, Jinlan Wei2, Haiyang Pang3, Wenxuan Wei1, Yu Sun1, Mengya He1, Yanling Sun1 1Department of Obstetrics, Yidu Central Hospital of Weifang, Shandong (China) 2Department of Public Health, Yidu Central Hospital of Weifang, Shandong (China) 3Department of Rehabilitation Medicine, Pingdu Peoples's Hospital, Shandong (China) Summary Objective: To analyze the characteristics of pregnant women with pre-gestational diabetes mellitus (PGDM) who had missed diag- nosis prior to pregnancy, and to evaluate the effects of diagnosis time on pregnancy outcomes in pregnant women with PGDM. Mate-rials and Methods: A total of 822 pregnant women who were diagnosed with PGDM were conducted in this study. They were divided into two groups, including pre-pregnancy diagnosis group and pregnancy diagnosis group based on the initial diagnosis time. Then in the pregnancy diagnosis group, the cases diagnosed before 24 gestational weeks were defined as group A, and those diagnosed at or after 24 gestational weeks were defined as Group B. Maternal and pregnancy variables, as well as pregnancy outcomes, including delivery age of pregnant women, the rate of pregnancy loss, delivery gestational weeks, neonatal birth weight, the proportion of insulin treat- ment, the rate of pre-term, macrosomia, newborns transferred to pediatrics, the average of HbA1c level, and preeclampsia, were ana- lyzed among groups by paired Student’s t-test. Results: The rate of missed diagnosis before pregnancy was 68.1%. The proportion of insulin treatment and the rate of the cesarean section had a significant difference between pre-pregnancy diagnosis group and preg- nancy diagnosis group. The characteristics and pregnancy outcomes in pregnancy diagnosis group A were not significantly different from those in the pre-pregnancy diagnosis group. However, in the pregnancy diagnosis group B, the proportion of pregnant women using in- sulin treatment and the average HbA1c level had a statistically significant difference, compared to pregnancy diagnosis group A, as well as the pre-pregnancy group. Conclusions: The rate of undiagnosed PGDM was high, and PGDM was significantly associated with mul- tiple adverse pregnancy outcomes. Fasting plasma glucose should be used as a screening test to identify PGDM at pre-pregnancy or first antenatal care. Key words: Pre-gestational diabetes mellitus; Pregnancy outcome; Diagnosis time.